Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$2.05 - $3.0 $47,506 - $69,522
-23,174 Reduced 68.21%
10,800 $32,000
Q2 2022

Aug 15, 2022

BUY
$2.2 - $3.98 $7,636 - $13,814
3,471 Added 11.38%
33,974 $101,000
Q1 2022

May 16, 2022

BUY
$3.74 - $4.55 $2,988 - $3,635
799 Added 2.69%
30,503 $117,000
Q4 2021

Feb 14, 2022

BUY
$3.9 - $4.75 $11,364 - $13,841
2,914 Added 10.88%
29,704 $124,000
Q3 2021

Nov 15, 2021

SELL
$4.57 - $5.39 $44,804 - $52,843
-9,804 Reduced 26.79%
26,790 $125,000
Q2 2021

Aug 16, 2021

BUY
$4.46 - $6.22 $118,488 - $165,246
26,567 Added 264.95%
36,594 $195,000
Q1 2021

May 17, 2021

SELL
$3.8 - $4.92 $8,645 - $11,193
-2,275 Reduced 18.49%
10,027 $45,000
Q4 2020

Feb 16, 2021

SELL
$3.45 - $4.28 $89 - $111
-26 Reduced 0.21%
12,302 $46,000
Q3 2020

Nov 16, 2020

SELL
$2.99 - $3.89 $40,780 - $53,055
-13,639 Reduced 52.52%
12,328 $44,000
Q2 2020

Aug 14, 2020

BUY
$2.56 - $3.37 $12,421 - $16,351
4,852 Added 22.98%
25,967 $80,000
Q1 2020

May 15, 2020

BUY
$2.98 - $5.22 $2,118 - $3,711
711 Added 3.48%
21,115 $67,000
Q4 2019

Feb 14, 2020

SELL
$4.37 - $5.67 $129,941 - $168,597
-29,735 Reduced 59.31%
20,404 $102,000
Q3 2019

Nov 14, 2019

BUY
$4.2 - $5.87 $99,132 - $138,549
23,603 Added 88.95%
50,139 $242,000
Q2 2019

Aug 14, 2019

SELL
$5.35 - $7.55 $98,049 - $138,368
-18,327 Reduced 40.85%
26,536 $153,000
Q1 2019

May 15, 2019

SELL
$5.81 - $7.6 $340,024 - $444,782
-58,524 Reduced 56.61%
44,863 $0
Q4 2018

Feb 14, 2019

BUY
$5.71 - $7.01 $83,554 - $102,577
14,633 Added 16.49%
103,387 $666,000
Q1 2018

May 11, 2018

BUY
$8.71 - $11.87 $773,047 - $1.05 Million
88,754 New
88,754 $905,000

Others Institutions Holding CO

# of Institutions
1
Shares Held
44.8K
Call Options Held
0
Put Options Held
0

About Global Cord Blood Corp


  • Ticker CO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 133,915,000
  • Description
  • Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matchin...
More about CO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.